Related Experiment Video

Updated: Jun 19, 2026

Rapid Whole-Mount High-Resolution Imaging of Small Animal Vasculature for Quantitative Studies
08:49

Rapid Whole-Mount High-Resolution Imaging of Small Animal Vasculature for Quantitative Studies

Published on: May 23, 2025

Small vessel vasculitis

Paul Brogan1, Despina Eleftheriou, Michael Dillon

  • 1Department of Rheumatology, Institute of Child Health, 30 Guilford St, London, WC1N1EH, UK. p.brogan@ich.ucl.ac.uk

Pediatric Nephrology (Berlin, Germany)
|November 4, 2009
PubMed

Insights

Pediatric small vessel vasculitides like Henoch-Schönlein purpura (HSP) and anti-neutrophil cytoplasmic antibody-associated vasculitides (AAV) have new classification criteria. Research gaps in clinical trial data and long-term outcomes persist for these childhood conditions.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Clinical Trials

Background:

  • Small vessel vasculitides in children include Henoch-Schönlein purpura (HSP) and anti-neutrophil cytoplasmic antibody-associated vasculitides (AAV).
  • Validated classification criteria for HSP and Wegener's granulomatosis (a type of AAV) are now available.
  • Understanding and treating these conditions in children presents unique challenges.

Purpose of the Study:

  • To review current knowledge on pediatric small vessel vasculitides, focusing on HSP and AAV.
  • To highlight the impact of new classification criteria on research.
  • To identify current therapeutic approaches and existing research gaps.

Main Methods:

  • Literature review of pediatric small vessel vasculitides.
  • Discussion of clinical manifestations and current therapies.
  • Analysis of existing clinical trial data and future research needs.

Main Results:

  • New validated classification criteria for HSP and Wegener's granulomatosis will aid future research.
  • Clinical manifestations of pediatric small vessel vasculitis are described.
  • Limited randomized controlled trial (RCT) data exists for HSP and pediatric AAV therapies.
  • Children with AAV are now included in an RCT comparing mycophenolate mofetil and cyclophosphamide.

Conclusions:

  • Validated classification criteria are a significant step forward for pediatric vasculitis research.
  • There is a critical need for robust clinical trial data and validated outcome measures for HSP and AAV.
  • Long-term outcome data for pediatric small vessel vasculitis survivors are lacking.
  • Further research is essential to improve diagnosis, treatment, and long-term management of these conditions.

More Related Videos

The ex vivo Isolated Skeletal Microvessel Preparation for Investigation of Vascular Reactivity07:00

The ex vivo Isolated Skeletal Microvessel Preparation for Investigation of Vascular Reactivity

Published on: April 28, 2012

Related Concept Videos

Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Venules01:08

Venules

Venules are an integral part of the microscopic circulatory system that bridges the gap between capillaries and veins.
Venules are much smaller in diameter compared to their larger counterparts, the veins. They are generally 8 to 100 micrometers in diameter, significantly smaller than the size of veins. The walls of venules are thin, consisting of the endothelium, a thin layer of connective tissue, and occasionally a few smooth muscle cells. This structural simplicity is a stark contrast...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...